Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

April 15, 2021

Study Completion Date

March 15, 2022

Conditions
Immune Evasion, TumorNeoplastic Cells, CirculatingCirculating Tumor CellPulmonary MetastasisColo-rectal Cancer
Interventions
RADIATION

RFA interventions

Each patient is treated with 2 RFA interventions. Abiopsy of one metastasis is done at each RF session. Histological samples are sent to the Bio-pathology department of Institut Bergonié for tumor infiltrating lymphocytes counting. Primary outcome results from this counting (stromal TILs ≥ 20% is considered as a significant level, a comparative measurement before and after RF will be performed). In parallel blood samples are performed before and after RFA to analyze the kinetics of peripheral blood T lymphocytes subsets, tumoral circulating cells and tumoral DNA.

Trial Locations (1)

33076

Institut Bergonie, Bordeaux

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Groupement Interrégional de Recherche Clinique et d'Innovation

OTHER

lead

Institut Bergonié

OTHER

NCT03960021 - Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin | Biotech Hunter | Biotech Hunter